Your session is about to expire
← Back to Search
Behavioral Intervention
MORE+JITAI for Chronic Pain (MORE-JITAI Trial)
N/A
Waitlist Available
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline through 1-month follow-up
Awards & highlights
MORE-JITAI Trial Summary
This trial studies how tech-based mindfulness may help people with chronic pain taking opioids in the long-term.
Eligible Conditions
- Chronic Pain
MORE-JITAI Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline through 1-month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline through 1-month follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in momentary craving
Change in momentary pain: numeric rating scale
Secondary outcome measures
Heart rate
Change in momentary positive affect
Change in momentary stress
Other outcome measures
Change in chronic pain symptoms
Change in mindful reinterpretation of pain sensations
Change in opioid dose
+2 moreMORE-JITAI Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness-Oriented Recovery Enhancement+JITAIExperimental Treatment1 Intervention
Participants will attend a telehealth Mindfulness-Oriented Recovery Enhancement (MORE) group plus mindfulness JITAI weekly for eight weeks.
Group II: Supportive PsychotherapyActive Control1 Intervention
Participants will attend a telehealth supportive psychotherapy group weekly for eight weeks.
Find a Location
Who is running the clinical trial?
University of UtahLead Sponsor
1,102 Previous Clinical Trials
1,779,198 Total Patients Enrolled
28 Trials studying Chronic Pain
4,770 Patients Enrolled for Chronic Pain
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger